OverviewChartNewsTraderScreen

HSBC WAR. CALL 01/25 22UA/  DE000HG1J8A9  /

gettex Zettex2
16/05/2024  21:36:05 Chg.0.0000 Bid21:58:09 Ask21:58:09 Underlying Strike price Expiration date Option type
0.0270EUR 0.00% 0.0240
Bid Size: 150,000		 0.0390
Ask Size: 150,000		 BIONTECH SE SPON. AD... 218.4658 - 15/01/2025 Call
TeleTrader 06/05 BioNTech's Q1 revenue slumps 85% to €187.6M
GlobeNewswire 06/05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 22/04 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 07/04 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
TeleTrader 20/03 BioNTech Q4 revenue plunges 65% to €1.48B
GlobeNewswire 20/03 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20/03 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 11/03 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 07/03 BioNTech Announces Planned Retirement of Sean Marett
GlobeNewswire 06/03 BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update ...
GlobeNewswire 08/02 BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Exp...
GlobeNewswire 31/01 BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjuga...
GlobeNewswire 22/01 BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/...
TeleTrader 09/01 BioNTech sees $3.3B revenue for 2024, expanding into oncology
GlobeNewswire 09/01 BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 21/12/2023 BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Can...
GlobeNewswire 18/12/2023 BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
GlobeNewswire 12/12/2023 BioNTech to Inaugurate First African Site on December 18, 2023
TeleTrader 06/11/2023 BioNTech Q3 revenue plummets 74% to €895M
GlobeNewswire 06/11/2023 BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
GlobeNewswire 26/10/2023 Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Agains...
GlobeNewswire 23/10/2023 BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advance...
GlobeNewswire 23/10/2023 BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to ...
GlobeNewswire 19/10/2023 BioNTech Expands Late-Stage Clinical Oncology Portfolio with Initiation of further Phase 2 Trial wit...
GlobeNewswire 16/10/2023 BioNTech to Present Multiple Program Updates Across Modalities at ESMO Congress 2023